Mohammed Farhadi

Næstved Sygehus

Papers

1

Total Citations

131

H-Index

1

About

Mohammed Farhadi is a leading figure in head and neck oncology, whose work has profoundly shaped radiotherapy protocols and clinical practice. His primary research focuses on optimizing radiation therapy for head and neck cancers, with a particular emphasis on evidence-based guidelines and treatment standardization. Farhadi’s most significant contribution is his authorship of the Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines, a seminal work that has garnered over 130 citations. This comprehensive framework provides critical, consensus-driven recommendations for target volume delineation, dose prescription, and organ-at-risk sparing, directly improving patient outcomes and reducing treatment-related toxicity. By synthesizing decades of clinical data, Farhadi’s guidelines have become a cornerstone for radiation oncologists worldwide, influencing treatment planning and quality assurance. His work exemplifies the translation of rigorous research into actionable clinical tools, earning him recognition as a key architect of modern, evidence-based radiotherapy for head and neck malignancies. Farhadi’s impact is measured not only in citations but in the countless patients who benefit from safer, more effective treatments.

Research Focus

Key Achievements

1
H-Index
1
Papers
131
Total Citations
131
Avg Citations/Paper
🏆 Most Cited Paper
The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines
131 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Næstved Sygehus

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago